The application of SILAC mouse in human body fluid proteomics analysis reveals protein patterns associated with IgA nephropathy

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Zhao, Shilin ^a   Li, Rongxia ^a   Cai, Xiaofan ^b   Chen, Wanjia ^b   Li, Qingrun ^a   Xing, Tao ^a   Zhu, Wenjie ^a   Chen, Y Eugene ^c   Zeng, Rong ^a   Deng, Yueyi ^b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; CERULOPLASMIN; COMPLEMENT COMPONENT C3; GLUCOCORTICOID; PIGMENT EPITHELIUM DERIVED FACTOR; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FLUID; DRUG DOSE REDUCTION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84878690653     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/275390     Document Type: Article

References (39)

1. Anderson N. L., Polanski M., Pieper R., The human plasma proteome: a nonredundant list developed by combination of four separate sources. Molecular & Cellular Proteomics 2004 3 4 311 326
2. Kristiansen T. Z., Bunkenborg J., Gronborg M., A proteomic analysis of human bile. Molecular & Cellular Proteomics 2004 3 7 715 728 (Pubitemid 39077002)
3. Taguchi A., Hanash S. M., Unleashing the power of proteomics to develop blood-based cancer markers. Clinical Chemistry 2012 59 1 119 126 10.1373/clinchem.2012.184572
4. Lollo B. A., Harvey S., Liao J., Improved two-dimensional gel electrophoresis representation of serum proteins by using ProtoClear. Electrophoresis 1999 20 4-5 854 859 (Pubitemid 29222441)
5. Adkins J. N., Varnum S. M., Auberry K. J., Moore R. J., Angell N. H., Smith R. D., Springer D. L., Pounds J. G., Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Molecular & Cellular Proteomics 2002 1 12 947 955 2-s2.0-0003206867
6. Neilson K. A., Ali N. A., Muralidharan S., Mirzaei M., Mariani M., Assadourian G., Lee A., Van Sluyter S. C., Haynes P. A., Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011 11 4 535 553 2-s2.0-79551500036 10.1002/pmic.201000553
7. Pottiez G., Wiederin J., Fox H. S., Ciborowski P., Comparison of 4-plex to 8-plex iTRAQ quantitative measurements of proteins in human plasma samples. Journal of Proteome Research 2012 11 7 3774 3781 10.1021/pr300414z
8. Sun W., Li F., Wu S., Wang X., Zheng D., Wang J., Gao Y. H., Human urine proteome analysis by three separation approaches. Proteomics 2005 5 18 4994 5001 2-s2.0-29544433936 10.1002/pmic.200401334 (Pubitemid 43016918)
9. Wanjia C., Jianpi bushen tongluo Decoction on Spleen Kidney Yang Deficiency and Blood Stasis Type, Progression of IgA Nephropathy. Chinese Journal of Integrated Traditional and Western Nephrology 2012 13 10 876 878
10. Li R., Xu W., Wang Z., Liang B., Wu J. R., Zeng R., Proteomic characteristics of the liver and skeletal muscle in the Chinese tree shrew (Tupaia belangeri chinensis). Protein Cell 2012 3 9 691 700 10.1007/s13238-012- 2039-0
11. Cox J., Mann M., MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nature Biotechnology 2008 26 12 1367 1372 2-s2.0-57449099865 10.1038/nbt.1511
12. Cox J., Neuhauser N., Michalski A., Scheltema R. A., Olsen J. V., Mann M., Andromeda: a peptide search engine integrated into the MaxQuant environment. Journal of Proteome Research 2011 10 4 1794 1805 2-s2.0-79953701087 10.1021/pr101065j
13. Bolstad B. M., Irizarry R. A., Åstrand M., Speed T. P., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003 19 2 185 193 2-s2.0-0037316303 10.1093/bioinformatics/19.2.185 (Pubitemid 36181903)
14. Kim K. Y., Kim B. J., Yi G. S., Reuse of imputed data in microarray analysis increases imputation efficiency. BMC Bioinformatics 2004 5, article 160 2-s2.0-13244298228 10.1186/1471-2105-5-160 (Pubitemid 40195348)
15. Smyth G. K., Gentleman R., Carey V., Huber W., Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005 New York, NY, USA Springer 397 420
16. Krüger M., Moser M., Ussar S., Thievessen I., Luber C. A., Forner F., Schmidt S., Zanivan S., Fässler R., Mann M., SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 2008 134 2 353 364 2-s2.0-47549099572 10.1016/j.cell.2008. 05.033 (Pubitemid 352010327)
17. Zanivan S., Krueger M., Mann M., In vivo quantitative proteomics: the SILAC mouse. Methods in Molecular Biology 2012 757 435 450
18. Ishihama Y., Sato T., Tabata T., Miyamoto N., Sagane K., Nagasu T., Oda Y., Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nature Biotechnology 2005 23 5 617 621 2-s2.0-22844436250 10.1038/nbt1086 (Pubitemid 41724902)
19. Zwirner J., Burg M., Schulze M., Brunkhorst R., Götze O., Koch K. M., Floege J., Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. Kidney International 1997 51 4 1257 1264 2-s2.0-0030940077 (Pubitemid 27186554)
20. Worthmann K., Peters I., Kmpers P., Saleem M., Becker J. U., Agustian P. A., Achenbach J., Haller H., Schiffer M., Urinary excretion of IGFBP-1 and -3 correlates with disease activity and differentiates focal segmental glomerulosclerosis and minimal change disease. Growth Factors 2010 28 2 129 138 2-s2.0-77949466251 10.3109/08977190903512594
21. Caramori M. L., Fioretto P., Mauer M., Enhancing the predictive value of urinary albumin for diabetic nephropathy. Journal of the American Society of Nephrology 2006 17 2 339 352 2-s2.0-33645450441 10.1681/ASN.2005101075
22. Yokota H., Hiramoto M., Okada H., Kanno Y., Yuri M., Morita S., Naitou M., Ichikawa A., Katoh M., Suzuki H., Absence of increased α 1-microglobulin in IgA nephropathy proteinuria. Molecular and Cellular Proteomics 2007 6 4 738 744 2-s2.0-34247379129 10.1074/mcp.M600366-MCP200 (Pubitemid 46630106)
23. Thrailkill K. M., Jo C. H., Cockrell G. E., Moreau C. S., Fowlkes J. L., Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? Journal of Clinical Endocrinology and Metabolism 2011 96 1 142 149 2-s2.0-78650909510 10.1210/jc.2010-0980
24. Nagai T., Tomizawa T., Nakajima K., Uehara Y., Mori M., Effect of nephropathy on the composition of apolipoprotein-containing particles in NIDDM. Journal of Atherosclerosis and Thrombosis 1998 5 2 54 59 2-s2.0-0032227718
25. Ito S., Fujita H., Narita T., Yaginuma T., Kawarada Y., Kawagoe M., Sugiyama T., Urinary copper excretion in type 2 diabetic patients with nephropathy. Nephron 2001 88 4 307 312 2-s2.0-0034939396 10.1159/000046013 (Pubitemid 32695885)
26. Moon P. G., Lee J. E., You S., Kim T. K., Cho J. H., Kim I. S., Kwon T. H., Kim C. D., Park S. H., Hwang D., Kim Y. L., Baek M. C., Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics 2011 11 12 2459 2475 2-s2.0-79958078403 10.1002/pmic.201000443
27. Chen H., Zheng Z., Li R., Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy. American Journal of Nephrology 2010 32 1 47 56 10.1159/000314326
28. Kanauchi M., Nishioka H., Hashimoto T., Dohi K., Diagnostic significance of urinary transferrin in diabetic nephropathy. Nippon Jinzo Gakkai Shi 1995 37 11 649 654 2-s2.0-0029401276
29. Komatsu H., Fujimoto S., Hara S., Sato Y., Yamada K., Eto T., Relationship between serum IgA/C3 ratio and progression of IgA nephropathy. Internal Medicine 2004 43 11 1023 1028 2-s2.0-10244229792 10.2169/ internalmedicine.43.1023 (Pubitemid 39619116)
30. Janssen U., Bahlmann F., Köhl J., Zwirner J., Haubitz M., Floege J., Activation of the acute phase response and complement C3 in patients with IgA nephropathy. American Journal of Kidney Diseases 2000 35 1 21 28 2-s2.0-0033979334 (Pubitemid 30027235)
31. Cumming A. D., Thomson D., Davison A. M., Robson J. S., Significance of urinary C3 excretion in glomerulonephritis. Journal of Clinical Pathology 1976 29 7 601 607 2-s2.0-0017161324
32. Eardley K. S., Ferreira M. A. S., Howie A. J., Gosling P., Lipkin G. W., Urinary albumin excretion: a predictor of glomerular findings in adults with microscopic haematuria. Monthly Journal of the Association of Physicians 2004 97 5 297 301 2-s2.0-2442696420 10.1093/qjmed/hch049 (Pubitemid 38659766)
33. Nakayama A., Odake J., Kanke A., Sakatsume M., Kasama T., Shiba K., Redox state of urinary albumin in patients with IgA nephropathy. Rinsho Byori 2011 59 11 1013 1018
34. Floege J., Feehally J., Treatment of IgA nephropathy and Henoch-Schonlein nephritis. Nature Reviews Nephrology 2013 10.1038/nrneph.2013.59
35. Agarwal R., Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clinical Journal of the American Society of Nephrology 2009 4 9 1523 1528 2-s2.0-73249129568 10.2215/CJN.02010309
36. Barragry J. M., France M. W., Carter N. D., Vitamin-D metabolism in nephrotic syndrome. The Lancet 1977 2 8039 629 632 2-s2.0-0017729681 (Pubitemid 8183111)
37. Shinada M., Akdeniz A., Panagiotopoulos S., Jerums G., Bach L. A., Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy. Journal of Clinical Endocrinology and Metabolism 2000 85 3 1163 1169 2-s2.0-0034454630 10.1210/jc.85.3.1163 (Pubitemid 32269366)
38. Cox S. N., Sallustio F., Serino G., Pontrelli P., Verrienti R., Pesce F., Torres D. D., Ancona N., Stifanelli P., Zaza G., Schena F. P., Altered modulation of WNT- Β -catenin and PI3K/Akt pathways in IgA nephropathy. Kidney International 2010 78 4 396 407 2-s2.0-77955175704 10.1038/ki.2010.138
39. Lim S. C., Liying D. Q., Toy W. C., Adipocytokine zinc alpha2 glycoprotein (ZAG) as a novel urinary biomarker for normo-albuminuric diabetic nephropathy. Diabetic Medicine 2012 29 7 945 949 10.1111/j.1464-5491.2011.03564. x